Understanding how the body reacts to common medical implant materials
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
This work explores how the body's immune system responds to a material called PEG, which is found in many medical devices and drug delivery systems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Engineering Experiment Station NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11123177 on NIH RePORTER |
What this research studies
Many medical devices and therapies use a material called Poly(ethylene glycol), or PEG, which was thought to be harmless. However, it's now known that many people have antibodies against PEG from everyday exposure, and we don't fully understand how this affects medical implants. This project aims to find out if these existing antibodies change how the body reacts to PEG-based implants. Researchers will test different types of PEG materials to see how the immune system responds over time.
Who could benefit from this research
Good fit: This foundational work does not directly involve patient participation but aims to benefit individuals who receive medical implants or therapies containing PEG.
Not a fit: Patients not receiving medical implants or therapies that contain PEG would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to safer and more effective medical implants and drug delivery systems for patients by helping us understand and overcome immune reactions.
How similar studies have performed: While the immunogenicity of PEGylated drugs has been observed, the impact of anti-PEG antibodies on the biocompatibility of PEG hydrogels in implants is a novel area of investigation.
Where this research is happening
College Station, United States
- Texas Engineering Experiment Station — College Station, United States (Active)
Researchers
- Principal investigator: Alge, Daniel — Texas Engineering Experiment Station
- Study coordinator: Alge, Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.